Gilead Sciences, Inc. announced that the U.S. FDA has granted expedited approval of a supplemental new drug application (sNDA) for...
Read moreMerck, known as MSD outside the United States and Canada, announced that the EC has approved KEYTRUDA, Merck’s anti-PD-1 therapy,...
Read moreModerna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Carisma Therapeutics Inc., a biopharmaceutical pioneer in...
Read morePfizer Inc. and Acuitas Therapeutics, a company focused on developing lipid nanoparticle (LNP) delivery systems to enable messenger RNA (mRNA)-based...
Read moreSanofi and Exscientia announced a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates...
Read moreGlaxoSmithKline plc and Vir Biotechnology, Inc. announced that the US Government will purchase an additional 600,000 doses of sotrovimab, an...
Read moreCatalent, the global leader in enabling biopharma, cell, gene and consumer health partners to optimize development, launch, and supply of...
Read moreEnvirotainer, the global market leader in secure cold chain solutions for air transportation of pharmaceuticals, today announced that Delta Cargo...
Read moreScientists at La Jolla Institute for Immunology (LJI) and Charles River Laboratories International, Inc., are launching a new project to...
Read moreCPhI Worldwide releases its beginning of year pharma market predictions for 2022 combining research from over 350 pharma executives and...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.